Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 2300 (Rev 02/2020) |
OMB No. 0651-0051 (Exp 11/30/2020) |
Input Field | Entered |
---|---|
SERIAL NUMBER | 88310367 |
LAW OFFICE ASSIGNED | LAW OFFICE 107 |
MARK SECTION | |
MARK | VIRASHIELD (standard characters, see http://tmng-al.uspto.gov /resting2/api/img/8831036 7/large) |
OWNER SECTION(current) | |
NAME | GlaxoSmithKline Consumer Healthcare (UK) IP Limited |
MAILING ADDRESS | 980 Great West Road |
CITY | Brentford, Middlesex |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United Kingdom |
ZIP/POSTAL CODE | TW89GS |
XXXX | |
ATTORNEY SECTION(current) | |
NAME | Terence A. Dixon |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | GSK |
INTERNAL ADDRESS | LBP - NY0300 |
STREET | 5 CRESENT DRIVE |
CITY | PHILADELPHIA |
STATE | Pennsylvania |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
POSTAL/ZIP CODE | 19112 |
PHONE | 484-885-9127 |
trademarks@gsk.com | |
DOCKET/REFERENCE NUMBER(S) | 82770362 |
CORRESPONDENCE SECTION(current) | |
NAME | Terence A. Dixon |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@gsk.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
DOCKET/REFERENCE NUMBER(S) | 82770362 |
OWNER SECTION(proposed) | |
STATEMENT TEXT |
By submission of this request, the undersigned requests that the following be made of record for the owner/holder: |
NAME | GlaxoSmithKline Consumer Healthcare (UK) IP Limited |
MAILING ADDRESS | 980 Great West Road |
CITY | Brentford, Middlesex |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United Kingdom |
ZIP/POSTAL CODE | TW89GS |
XXXX | |
STATEMENT OF THE REASON FOR REPLACEMENT | |
Terence A. Dixon is no longer employed at GlaxoSmithKline Consumer Healthcare (UK) IP Limited. | |
ATTORNEY SECTION (proposed) | |
STATEMENT TEXT | By submission of this request, the undersigned confirms that (1) representation is ongoing and (2) that the individual listed below should now be identified as the attorney of record: |
NAME | Arrielle Millstein |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | GSK |
OTHER APPOINTED ATTORNEY(S) | Michele A. Farber, Christopher M. Hanes, Merilee Arevalo |
INTERNAL ADDRESS | NY0300 |
STREET | 5 CRESCENT DRIVE |
CITY | PHILADELPHIA |
STATE | Pennsylvania |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
POSTAL/ZIP CODE | 19112 |
PHONE | 201-370-7293 |
trademarks@gsk.com | |
DOCKET/REFERENCE NUMBER(S) | 82770362 |
DOMESTIC REPRESENTATIVE SECTION (proposed) | |
STATEMENT TEXT | By submission of this request, the undersigned hereby appoints the following new domestic representative upon whom notices or process affecting the mark may be served or changes the address of an existing domestic representative of record: |
NAME | Arrielle Millstein |
FIRM NAME | GSK |
INTERNAL ADDRESS | NY0300 |
STREET | 5 CRESCENT DRIVE |
CITY | PHILADELPHIA |
STATE | Pennsylvania |
POSTAL/ZIP CODE | 19112 |
PHONE | 201-370-7293 |
trademarks@gsk.com | |
CORRESPONDENCE SECTION (proposed) | |
NAME | Arrielle Millstein |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@gsk.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
DOCKET/REFERENCE NUMBER(S) | 82770362 |
SIGNATURE SECTION | |
SIGNATURE | /ASM/ |
SIGNATORY NAME | Arrielle Millstein |
SIGNATORY DATE | 06/09/2020 |
SIGNATORY POSITION | Attorney of record, NY bar member |
SIGNATORY PHONE NUMBER | 201-370-7293 |
AUTHORIZED SIGNATORY | YES |
FILING INFORMATION SECTION | |
SUBMIT DATE | Tue Jun 09 12:37:52 ET 2020 |
TEAS STAMP | USPTO/CAR-XXX.XX.XX.X-202 00609123752426958-8872511 1-7107db1c053beffbaf8d69d 704b4cd6bb87a666c9fee5172 d526d2464b5121c7-N/A-N/A- 20200609103425272633 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 2300 (Rev 02/2020) |
OMB No. 0651-0051 (Exp 11/30/2020) |